Cite
Increased visinin-like protein-1, YKL-40, lipocalin-2, and IL-23 levels in patients with migraine
MLA
Dündar, A. ..Cafer, V. ..Aslanhan, H. ..Özdemir, H. H. ..Yilmaz, A. .. &.Çevik, M. U., et al. Increased Visinin-like Protein-1, YKL-40, Lipocalin-2, and IL-23 Levels in Patients with Migraine. Jan. 2022. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....fc670378f55a18af608eb720f9199ee1&authtype=sso&custid=ns315887.
APA
Dündar, A. . C. V. . A. H. . Ö. H. H. . Y. A. . & Ç. M. U., Dündar, A., Cafer, V., Aslanhan, H., Özdemir, H. H., Yılmaz, A., & Cevik, M. U. (2022). Increased visinin-like protein-1, YKL-40, lipocalin-2, and IL-23 levels in patients with migraine.
Chicago
Dündar, A., Cafer, V., Aslanhan, H., Özdemir, H. H., Yilmaz, A., & Çevik, M. U., Ahmet Dündar, Vugar Cafer, Hamza Aslanhan, Hasan Hüseyin Özdemir, Ahmet Yılmaz, and Mehmet Ugur Cevik. 2022. “Increased Visinin-like Protein-1, YKL-40, Lipocalin-2, and IL-23 Levels in Patients with Migraine,” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....fc670378f55a18af608eb720f9199ee1&authtype=sso&custid=ns315887.